Jazz Pharmaceuticals plc - SHS USD (JAZZ)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / SHS USD
Total 13F shares
53,038,068
Share change
+436,523
Total reported value
$8,702,251,467
Put/Call ratio
41%
Price per share
$164.37
Number of holders
430
Value change
+$71,250,038
Number of buys
193
Number of sells
207

Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q1 2021

As of 31 Mar 2021 Jazz Pharmaceuticals plc - SHS USD (JAZZ) had 430 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 53,038,068 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, LSV ASSET MANAGEMENT, JPMORGAN CHASE & CO, WELLINGTON MANAGEMENT GROUP LLP, CITADEL ADVISORS LLC, and AQR CAPITAL MANAGEMENT LLC.
This table shows 435 institutional shareholders of the security as of 31 Mar 2021.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.